Grants for City or township governments - Health

This funding opportunity provides financial support to various organizations to assist the Botswana Ministry of Health in implementing effective HIV prevention and treatment programs, particularly for underserved populations.

The "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II" grant aims to expand the existing mental health research network to include larger studies, provide guidance to the scientific community, and support career development for researchers from low-resource settings worldwide.

This funding opportunity supports early-career scientists in the U.S. who are focused on conducting impactful research to improve worker health and safety in various industries.

The Emergency Solutions Grants (ESG) Program is designed to assist persons experiencing homelessness or at risk of becoming homeless across the state. Managed by the State Housing Trust Fund for the Homeless Commission and Federal HUD, the ESG Program offers sub-awards to local government entities and non-profit organizations to deliver street outreach, emergency shelter, rapid re-housing, homelessness prevention, and related services at the local level. The program aims to operate within a continuum of assistance to help individuals and families move towards housing sustainability. It supports targeted populations, including single women, men, youth, veterans, families, and those experiencing domestic violence. Grant renewed every year.

This funding opportunity supports educational programs that promote diversity in neuroscience research by providing mentoring, research experiences, and skill development for underrepresented individuals in the field.

This funding opportunity supports researchers in exploring and validating the biological mechanisms linking HIV, substance use disorders, and opioid exposure at a single-cell level, with a focus on data mining existing datasets and conducting functional validation studies.

This grant provides funding for researchers to develop and test innovative behavioral treatments for individuals struggling with drug and alcohol misuse, particularly focusing on improving treatment effectiveness and accessibility for diverse populations.

This program will help rural hospitals expand their services to meet community health needs while increasing their revenues. The program will achieve these goals by providing expert technical assistance to rural hospitals to conduct market assessments, determine ways to enhance existing service lines, and start new service lines to keep services locally. The program will also provide direct financial support to help with associate costs of service lines. This program will also have the affect of helping facilities address long-standing rural disparities.

This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.

This grant provides funding to nonprofit organizations and government entities to deliver essential family planning and reproductive health services to low-income and underserved populations across the United States.

The City of Naperville has received National Multistate Opioid Settlement funds from the State of Illinois. The City Council has approved $100,000 of these funds to be awarded in grants specifically for opioid remediation programs and services this calendar year. Settlement restrictions apply. Please review the guidelines below before beginning your application: 1) Organizations applying are not required to be a non-profit 501(c)(3) or recognized by the State of Illinois as a non-profit organization. School districts, medical providers, coalitions and faith communities are welcome to apply, as are non-profit organizations and providers. Entities that have already received 2024 City of Naperville grant funding are eligible to apply for additional funding. 2) Programs and services must qualify as an Approved Abatement Program and impact Naperville residents. Approved Abatement Programs include the following: 4) Grants are reimbursement-based. Grantees must accrue costs prior to requesting reimbursement from the City of Naperville. 5) Applications are available May 1, 2024 and due May 31, 2024. 6) Grant funds will be awarded in June 2024 and must be expended, with reimbursements processed, by December 31, 2024. Please tailor your request to ensure that you can expend your funds within this timeframe. A Final Program & Financial Report must be filed by January 31, 2025. By submission of this application you are certifying that to the best of your knowledge and belief, data in this application is true and correct, the document has been duly authorized by the governing body of the applicant, and the applicant will comply with all regulations applicable to City of Naperville grant programs and settlement restrictions. Submit completed grant applications with attachments (Zip file recommended) to: Miranda Barfuss Community Grants Coordinator 630-305-5315 barfussm@naperville.il.us

The Otto Bremer Trust (OBT) is implementing new grantmaking approaches to effectively invest in people, places, and opportunities in Minnesota, Montana, North Dakota, and Wisconsin. The new model includes Strategic Grants and Community Responsive Fund grants. Strategic Grants are awarded directly by OBT to organizations with at least $500,000 in expenses from the previous year, aligning with OBT's objectives. Community Responsive Fund grants are managed by intermediary partners, focusing on organizations with less than $500,000 in expenses.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA (see RFA-HL-22-011).

The Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) aims to support licensed neurologists and neurosurgeons in the NINDS intramural program as they transition to independent academic positions while leading clinical trials and advancing their research careers in neuroscience.

This funding opportunity supports research projects that investigate the long-term impacts of disasters on healthcare systems serving vulnerable populations in the U.S., aiming to improve access and reduce health disparities.

This funding opportunity supports U.S.-based small businesses in the clinical validation of biomarkers for neurological or neuromuscular disorders, promoting inclusivity and collaboration while ensuring rigorous scientific standards for potential diagnostic and therapeutic applications.

This program provides funding for municipalities and nonprofit organizations in Connecticut to implement small-scale projects that improve community living for residents, particularly those aged 50 and older.

Reissue of PAR-20-118. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies Projects seeking support for a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach should consider the companion U19 FOA.

This grant provides funding for research studies that explore the relationship between autophagy, HIV infection, and substance use disorders, aiming to uncover mechanisms that could lead to new therapeutic strategies for affected individuals.